AR-L 100 BS
| Code | Size | Price |
|---|
| TAR-T30133-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
AR-L 100 BS is a bioactive chemical with cardiovascular effects and blood pressure.
CAS:
77303-18-5
Formula:
C16H17N3O3S
Molecular Weight:
331.39
Purity:
0.98
SMILES:
COc1ccc(-c2nc3ncccc3[nH]2)c(OCCS(C)=O)c1
References
1. Verrijk R, Vleeming W, van Rooij HH, Wemer J, Porsius AJ. Positive inotropic effects of milrinone, sulmazole and AR-L100 on isolated normal and infarcted hearts of the rat. Arch Int Pharmacodyn Ther. 1989 Jan-Feb;297:7-17. PubMed PMID: 2730243.
2. Hayes JS, Wyss VL, Wilson HC, Robertson DW, Kauffman RF. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100. J Pharmacol Exp Ther. 1986 Nov;239(2):375-81. PubMed PMID: 3021955.
3. Diederen W, Kadatz R. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS. Arzneimittelforschung. 1981;31(1a):141-6. PubMed PMID: 7195207.